中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2013年
22期
193-194,196
,共3页
股骨干%良性肿瘤%刮除植骨术%病理性骨折
股骨榦%良性腫瘤%颳除植骨術%病理性骨摺
고골간%량성종류%괄제식골술%병이성골절
Femoral shaft%Benign bone tumor%Cufettage and bone grafting%Pathological fracture
目的:探讨刮除植骨术治疗股骨干良性骨肿瘤后早期发生病理性骨折的相关因素。方法对53例股骨干良性骨肿瘤行刮除植骨治疗的患者的临床资料进行回顾性分析,根据是否发生术后早期病理性骨折分为骨折组和非骨折组,比较两组的临床资料,分析导致术后早期病理性骨折的相关因素。结果单因素分析结果显示,骨窗缺损长/宽比和肿瘤学分级两组差异有统计学意义(P<0.01)。多因素分析结果显示骨窗缺损长/宽比和肿瘤学分级与股骨干良性骨肿瘤患者性刮除植骨术后发生早期病理性骨折的具有相关性(P<0.05)。结论骨窗缺损长/宽比值大、肿瘤学分级中活跃期、侵袭期是导致术后发生病理性骨折的危险因素,在临床工作中应根据情况注意预防。
目的:探討颳除植骨術治療股骨榦良性骨腫瘤後早期髮生病理性骨摺的相關因素。方法對53例股骨榦良性骨腫瘤行颳除植骨治療的患者的臨床資料進行迴顧性分析,根據是否髮生術後早期病理性骨摺分為骨摺組和非骨摺組,比較兩組的臨床資料,分析導緻術後早期病理性骨摺的相關因素。結果單因素分析結果顯示,骨窗缺損長/寬比和腫瘤學分級兩組差異有統計學意義(P<0.01)。多因素分析結果顯示骨窗缺損長/寬比和腫瘤學分級與股骨榦良性骨腫瘤患者性颳除植骨術後髮生早期病理性骨摺的具有相關性(P<0.05)。結論骨窗缺損長/寬比值大、腫瘤學分級中活躍期、侵襲期是導緻術後髮生病理性骨摺的危險因素,在臨床工作中應根據情況註意預防。
목적:탐토괄제식골술치료고골간량성골종류후조기발생병이성골절적상관인소。방법대53례고골간량성골종류행괄제식골치료적환자적림상자료진행회고성분석,근거시부발생술후조기병이성골절분위골절조화비골절조,비교량조적림상자료,분석도치술후조기병이성골절적상관인소。결과단인소분석결과현시,골창결손장/관비화종류학분급량조차이유통계학의의(P<0.01)。다인소분석결과현시골창결손장/관비화종류학분급여고골간량성골종류환자성괄제식골술후발생조기병이성골절적구유상관성(P<0.05)。결론골창결손장/관비치대、종류학분급중활약기、침습기시도치술후발생병이성골절적위험인소,재림상공작중응근거정황주의예방。
Objective To discuss influencing factors of cufettage and bone grafting in treatment of femoral benign bone tumor postoperative complications of pathological fracture. Methods Clinical data of 53 cases with femoral benign bone tumor were retrospectively analyzed. All subjects were divided into fracture group and non-fracture group. Influencing factors of postoperative complications of pathological fracture were analyzed. Results Results of single-factor analysis showed length/wide of bone defect, oncology classification showed significant differences between two groups(P< 0.01). Results of multiple-factor analysis showed length/wide of bone defect, oncology classification were influencing factors of postoperative complications of pathological fracture (P<0.05). Conclusion With big ratio of length/wide of bone defect being, active phase and stage of invasion are influencing factors of postoperative pathological fracture .